Conference Call to be on Tuesday, July 15, at 4:15 PM EDT

Simulations Plus Releases Major Software Update for its Top Rated Predictive Software
ADMET Predictor™ 3.0 Employs New Technology for Molecular Descriptors, All New Predictive Models

U.S. EPA Licenses Simulations Plus’ ADMET Predictor™ Software
Agency Licenses Both Toxicity and New Enslein Metabolism Modules

Simulations Plus Releases Software Update for Better Pharmaceutical Drug Design
ClassPharmer™ 4.5 Adds Powerful New Capabilities for Drug Molecule Design and Data Mining

Simulations Plus Software Most Accurate in Comparison Study
Pfizer Study Presented at International Society for the Study of Xenobiotics (ISSX) Meeting in Shanghai

Simulations Plus Releases Major GastroPlus™ Software Update
Version 6.0 Incorporates Major Upgrades to Several Modules, Additional User Conveniences

GlaxoSmithKline Renews and Expands Global License for Simulations Plus Software
Company Adds Parsippany, NJ Site to Multi-year Agreement

Simulations Plus Reports Second Quarter and Six Months FY2008 Financial Results
Revenues Up 4.3%, and Earnings Up 9.0% for First 6 Months of FY2008

Simulations Plus Sets Date for Second Quarter Earnings Release and Conference Call
Conference Call to Be on Tuesday, April 15, at 4:15 PM EDT

U.S. FDA Renews and Expands GastroPlus(TM) Software License
Adds New ADMET Predictor(TM) Module

Simulations Plus’ Software Selected Application of Choice by Premier Pharmaceutical Company
Top 3 Company Adds Software Licenses to Multi-year Agreement

Simulations Plus Releases Major Upgrade to ADMET Predictor™ Software
Version 2.4 Adds Industry’s First Metabolism Kinetics Module for Key Enzymes

Simulations Plus Reports First Quarter FY2008 Financial Results
Revenues Increase 36%, Earnings Increase 232%

Simulations Plus Releases Major Upgrade To GastroPlus(™) Software
Version 5.3 Further Enhances Industry's Gold Standard Product

Experienced Formulation Scientist Becomes Director of Life Sciences
Dr. John Crison Joins Simulations Plus

Simulations Plus and Enslein Research Sign Agreement
Prediction of Metabolism from Important Group of Enzymes to be Added to ADMET Predictor™

Simulations Plus Reports Fourth Quarter and Fiscal Year 2007 Preliminary Revenues
Another New Record Set for Quarterly and Annual Revenues